Treatment with the Hyaluronic Acid Synthesis Inhibitor 4-Methylumbelliferone Suppresses LPS-Induced Lung Inflammation

Inflammation

Volumn 38, Issue 3, 2015, Pages 1250-1259

  McKallip, Robert J ^a   Ban, Hao ^a   Uchakina, Olga N ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acute lung inflammation; extracellular matrix; hyaluronic acid; LPS

Indexed keywords

CYTOKINE; GLUCURONOSYLTRANSFERASE; HYALURONAN SYNTHASE; HYALURONIC ACID; HYMECROMONE; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ACUTE LUNG INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; INFLAMMATION; LUNG; MOUSE; PATHOLOGY; PNEUMONIA; RESPIRATORY DISTRESS SYNDROME, ADULT; SPLEEN;

ACUTE LUNG INJURY; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; GLUCURONOSYLTRANSFERASE; HYALURONIC ACID; HYMECROMONE; INFLAMMATION; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED C57BL; PNEUMONIA; RESPIRATORY DISTRESS SYNDROME, ADULT; RNA, MESSENGER; SPLEEN;

EID: 84940004666     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-0092-y     Document Type: Article

References (43)

1. Bhatia, M., and S. Moochhala. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. The Journal of Pathology 202: 145–156.
2. Rubenfeld, G.D., E. Caldwell, E. Peabody, J. Weaver, D.P. Martin, M. Neff, et al. 2005. Incidence and outcomes of acute lung injury. The New England Journal of Medicine 353: 1685–1693.
3. Rubenfeld, G.D., and M.S. Herridge. 2007. Epidemiology and outcomes of acute lung injury. Chest 131: 554–562.
4. Shafeeq, H., and I. Lat 2012. Pharmacotherapy for acute respiratory distress syndrome. Pharmacotherapy. 32:943–57. doi:10.1002/j.1875-9114.2012.01115.
5. Bao, A., L. Liang, F. Li, M. Zhang, and X. Zhou. 2013. Consequences of acute ozone exposure imposed on the culminated allergic pulmonary inflammation in an established murine model of asthma. Frontiers in Bioscience 18: 838–851.
6. Liang, J., D. Jiang, Y. Jung, T. Xie, J. Ingram, T. Church, et al. 2011. Role of hyaluronan and hyaluronan-binding proteins in human asthma. The Journal of Allergy and Clinical Immunology 128: 403–411. e3.
7. Yoon, J.S., H.J. Lee, S.H. Choi, E.J. Chang, S.Y. Lee, and E.J. Lee. 2011. Quercetin inhibits IL-1beta-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves’ orbitopathy. PloS One 6: e26261.
8. Campo, G.M., A. Avenoso, S. Campo, A. D’Ascola, G. Nastasi, and A. Calatroni. 2010. Small hyaluronan oligosaccharides induce inflammation by engaging both toll-like-4 and CD44 receptors in human chondrocytes. Biochemical Pharmacology 80: 480–490.
9. Ernst, G., S. Lompardia, R. Cordo Russo, V. Gentilini, S. Venturiello, F. Galindez, et al. 2012. Corticosteroid administration reduces the concentration of hyaluronan in bronchoalveolar lavage in a murine model of eosinophilic airway inflammation. Inflammation Research 61: 1309–1317.
10. Esser, P.R., U. Wolfle, C. Durr, F.D. von Loewenich, C.M. Schempp, M.A. Freudenberg, et al. 2012. Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation. PloS One 7: e41340.
11. Stern, R., A.A. Asari, and K.N. Sugahara. 2006. Hyaluronan fragments: An information-rich system. European Journal of Cell Biology 85: 699–715.
12. Baeva, L.F., D.B. Lyle, M. Rios, J.J. Langone, and M.M. Lightfoote. 2014. Different molecular weight hyaluronic acid effects on human macrophage interleukin 1beta production. Journal of Biomedical Materials Research. Part A 102: 305–314.
13. Sokolowska, M., L.Y. Chen, M. Eberlein, A. Martinez-Anton, Y. Liu, S. Alsaaty, et al. 2014. Low molecular weight hyaluronan activates cytosolic phospholipase A2alpha and eicosanoid production in monocytes and macrophages. The Journal of Biological Chemistry 289: 4470–4488.
14. Bollyky, P.L., J.D. Lord, S.A. Masewicz, S.P. Evanko, J.H. Buckner, T.N. Wight, et al. 2007. Cutting edge: High molecular weight hyaluronan promotes the suppressive effects of CD4+ CD25+ regulatory T cells. Journal of Immunology 179: 744–747.
15. Mohamadzadeh, M., H. DeGrendele, H. Arizpe, P. Estess, and M. Siegelman. 1998. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. The Journal of Clinical Investigation 101: 97–108.
16. Singleton, P.A., T. Mirzapoiazova, Y. Guo, S. Sammani, N. Mambetsariev, F.E. Lennon, et al. 2010. High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness. American Journal of Physiology. Lung Cellular and Molecular Physiology 299: L639–L651.
17. Asari, A., T. Kanemitsu, and H. Kurihara. 2010. Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium. The Journal of Biological Chemistry 285: 24751–24758.
18. Uchakina, O.N., C.M. Castillejo, C.C. Bridges, and R.J. McKallip. 2013. The role of hyaluronic acid in SEB-induced acute lung inflammation. Clinical Immunology 146: 56–69.
19. Uchakina, O.N., H. Ban, and R.J. McKallip 2013. Targeting hyaluronic acid production for the treatment of leukemia: Treatment with 4-methylumbelliferone leads to induction of MAPK-mediated apoptosis in K562 leukemia. Leukemia Research. 1294–301. doi:10.1016/j.leukres.2013.07.009.
20. Sun, J., G.P. Law, C.C. Bridges, and R.J. McKallip. 2012. CD44 as a novel target for treatment of staphylococcal enterotoxin B-induced acute inflammatory lung injury. Clinical Immunology 144: 41–52.
21. Udaka, K. 1970. Proceedings of the Society for Experimental Biology and Medicine 133: 1384.
22. Lokeshwar, V.B., L.E. Lopez, D. Munoz, A. Chi, S.P. Shirodkar, S.D. Lokeshwar, et al. 2010. Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells. Cancer Research 70: 2613–2623.
23. McKallip, R.J., H.F. Hagele, and O.N. Uchakina. 2013. Treatment with the hyaluronic acid synthesis inhibitor 4-methylumbelliferone suppresses SEB-induced lung inflammation. Toxins (Basel) 5: 1814–1826.
24. Urakawa, H., Y. Nishida, J. Wasa, E. Arai, L. Zhuo, K. Kimata, et al. 2012. Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo. International Journal of Cancer 130: 454–466.
25. Arai, E., Y. Nishida, J. Wasa, H. Urakawa, L. Zhuo, K. Kimata, et al. 2011. Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo. British Journal of Cancer 105: 1839–1849.
26. Edward, M., J.A. Quinn, S.M. Pasonen-Seppanen, B.A. McCann, and R.H. Tammi. 2010. 4-Methylumbelliferone inhibits tumour cell growth and the activation of stromal hyaluronan synthesis by melanoma cell-derived factors. The British Journal of Dermatology 162: 1224–1232.
27. Piccioni, F., M. Malvicini, M.G. Garcia, A. Rodriguez, C. Atorrasagasti, N. Kippes, et al. 2012. Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice. Glycobiology 22: 400–410.
28. McKallip, R.J., Y. Do, M.T. Fisher, J.L. Robertson, P.S. Nagarkatti, and M. Nagarkatti. 2002. Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens. International Immunology 14: 1015–1026.
29. Itano, N., T. Sawai, M. Yoshida, P. Lenas, Y. Yamada, M. Imagawa, et al. 1999. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. The Journal of Biological Chemistry 274: 25085–25092.
30. Doi, K., A. Leelahavanichkul, P.S. Yuen, and R.A. Star. 2009. Animal models of sepsis and sepsis-induced kidney injury. The Journal of Clinical Investigation 119: 2868–2878.
31. Goodman, R.B., J. Pugin, J.S. Lee, and M.A. Matthay. 2003. Cytokine-mediated inflammation in acute lung injury. Cytokine & Growth Factor Reviews 14: 523–535.
32. Nakazawa, H., S. Yoshihara, D. Kudo, H. Morohashi, I. Kakizaki, A. Kon, et al. 2006. 4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells. Cancer Chemotherapy and Pharmacology 57: 165–170.
33. Campo, G.M., A. Avenoso, S. Campo, A. D’Ascola, P. Traina, C.A. Rugolo, et al. 2010. Differential effect of molecular mass hyaluronan on lipopolysaccharide-induced damage in chondrocytes. Innate Immunity 16: 48–63.
34. Pauloin, T., M. Dutot, F. Joly, J.M. Warnet, and P. Rat. 2009. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Molecular Vision 15: 577–583.
35. Ruffell, B., and P. Johnson. 2008. Hyaluronan induces cell death in activated T cells through CD44. Journal of Immunology 181: 7044–7054.
36. Kultti, A., S. Pasonen-Seppanen, M. Jauhiainen, K.J. Rilla, R. Karna, E. Pyoria, et al. 2009. 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Experimental Cell Research 315: 1914–1923.
37. Daines, D.A., J. Sun, O.N. Uchakina, and R.J. McKallip 2013. Development of a novel treatment for leukemia directed at tumor-associated mRNA splicing. Leukemia Research. 1125–31. doi:10.1016/j.leukres.2013.06.017.
38. Yoshida, M., N. Itano, Y. Yamada, and K. Kimata. 2000. In vitro synthesis of hyaluronan by a single protein derived from mouse HAS1 gene and characterization of amino acid residues essential for the activity. The Journal of Biological Chemistry 275: 497–506.
39. Bollyky, P.L., R.P. Wu, B.A. Falk, J.D. Lord, S.A. Long, A. Preisinger, et al. 2011. ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proceedings of the National Academy of Sciences of the United States of America 108: 7938–7943.
40. Jiang, D., J. Liang, J. Fan, S. Yu, S. Chen, Y. Luo, et al. 2005. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nature Medicine 11: 1173–1179.
41. Jiang, D., J. Liang, and P.W. Noble. 2011. Hyaluronan as an immune regulator in human diseases. Physiological Reviews 91: 221–264.
42. Teder, P., R.W. Vandivier, D. Jiang, J. Liang, L. Cohn, E. Pure, et al. 2002. Resolution of lung inflammation by CD44. Science 296: 155–158.
43. Bollyky, P.L., B.A. Falk, R.P. Wu, J.H. Buckner, T.N. Wight, and G.T. Nepom. 2009. Intact extracellular matrix and the maintenance of immune tolerance: High molecular weight hyaluronan promotes persistence of induced CD4+ CD25+ regulatory T cells. Journal of Leukocyte Biology 86: 567–572.